Head and Neck Cancer Trial, Recruiting NCT05542706 Sponsor: Centre Henri Becquerel Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05542706
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 85 years old
  • People whose general health and ability to carry out daily activities meets a certain minimum level (known as ECOG score of 2 or below — confirm with trial site if unsure what this means)
  • People diagnosed with a specific type of cancer called squamous-cell carcinoma located in the head or neck area (larynx, pharynx, oropharynx, mouth, or upper jaw), at a mid-to-advanced stage, that has not spread to other parts of the body, and where the treatment plan — as decided by a specialist cancer team — involves surgery followed by radiotherapy
  • People who are not currently subject to any court-ordered legal measures (confirm with trial site)
  • People who have signed a form confirming they understand and agree to take part
  • People who are covered by a health insurance or national health system

Who may not be able to join:

  • People whose treatment plan involves having radiotherapy before surgery, or having surgery on an area that has already been treated with radiotherapy in the past
  • People whose caregiver does not agree to participate, as the trial requires both the patient and their caregiver to take part together
  • People with a history of psychological difficulties or sensory impairments that could prevent them from fully understanding what participation in the study involves

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yveline David, Centre Henri Becquerel

Phone: +33232082542

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Henri Becquerel
Registry
ClinicalTrials.gov
Start date
31 October 2022
Est. completion
31 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of the impact of paramedical care on the caregiving burden between the two groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov